Tuberculosis impacts multiple aspects in quality of life in a Romanian cohort of drug-susceptible and drug resistant patients: A patient-reported outcome measures study.
clinical management
public health
quality of life
tuberculosis
Journal
Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576
Informations de publication
Date de publication:
24 May 2024
24 May 2024
Historique:
medline:
25
5
2024
pubmed:
25
5
2024
entrez:
25
5
2024
Statut:
aheadofprint
Résumé
Tuberculosis (TB), and especially its drug resistant forms, is responsible for not only significant mortality, but also considerable morbidity, still under-quantified. This study used four Patient-Reported Outcome Measures (PROMS) to assess the status of persons affected by drug-susceptible and drug-resistant TB during their TB treatment or after treatment completion, in Romania, the highest TB burden country in the EU. People affected by TB in two different regions in Romania were included during and after treatment, following a cross-sectional design. PROMs used were SF-36, EQ-5D-5L, WPAI and the app-based audiometry screening tool 'uHear.' Descriptive statistics and relevant statistical tests were used to compare groups between themselves and with the general Romanian population. Both patients with drug-susceptible and drug-resistant TB experience, with drug-resistant patients experiencing statistically significantly more pain and hearing loss. PROMs show some improvement in the after-treatment group; however, compared with the general Romanian population for which data were available, all groups scored lower on all outcome measures. PROMs offer the possibility of obtaining a more comprehensive view of patients' status, by involving them directly in the medical process and could guide a rehabilitation strategy.
Sections du résumé
BACKGROUND
BACKGROUND
Tuberculosis (TB), and especially its drug resistant forms, is responsible for not only significant mortality, but also considerable morbidity, still under-quantified. This study used four Patient-Reported Outcome Measures (PROMS) to assess the status of persons affected by drug-susceptible and drug-resistant TB during their TB treatment or after treatment completion, in Romania, the highest TB burden country in the EU.
METHODS
METHODS
People affected by TB in two different regions in Romania were included during and after treatment, following a cross-sectional design. PROMs used were SF-36, EQ-5D-5L, WPAI and the app-based audiometry screening tool 'uHear.' Descriptive statistics and relevant statistical tests were used to compare groups between themselves and with the general Romanian population.
RESULTS
RESULTS
Both patients with drug-susceptible and drug-resistant TB experience, with drug-resistant patients experiencing statistically significantly more pain and hearing loss. PROMs show some improvement in the after-treatment group; however, compared with the general Romanian population for which data were available, all groups scored lower on all outcome measures.
CONCLUSION
CONCLUSIONS
PROMs offer the possibility of obtaining a more comprehensive view of patients' status, by involving them directly in the medical process and could guide a rehabilitation strategy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Union Horizon 2020 Research and Innovation Programme
ID : 713660
Informations de copyright
© 2024 The Author(s) Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
Références
Churruca K, Pomare C, Ellis LA, Long JC, Henderson SB, Murphy LED, et al. Patient‐reported outcome measures (PROMs): a review of generic and condition‐specific measures and a discussion of trends and issues. Health Expect. 2021;24(4):1015–1024. https://doi.org/10.1111/hex.13254
Bagcchi S. WHO's global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20. https://doi.org/10.1016/S2666-5247(22)00359-7
Alene KA, Wangdi K, Colquhoun S, Chani K, Islam T, Rahevar K, et al. Tuberculosis related disability: a systematic review and meta‐analysis. BMC Med. 2021;19(1):203. https://doi.org/10.1186/s12916-021-02063-9
Prasanna T, Jeyashree K, Chinnakali P, Bahurupi Y, Vasudevan K, Das M. Catastrophic costs of tuberculosis care: a mixed methods study from Puducherry, India. Glob Health Action. 2018;11(1):1477493. https://doi.org/10.1080/16549716.2018.1477493
Meghji J, Gregorius S, Madan J, Chitimbe F, Thomson R, Rylance J, et al. The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting. Thorax. 2021;76(4):387–395. https://doi.org/10.1136/thoraxjnl-2020-215338
Araia ZZ, Mesfin AB, Mebrahtu AH, Tewelde AG, Tewelde AT, Ngusbrhan KS. Health‐related quality of life in tuberculosis patients in Eritrea: comparison among drug‐susceptible and rifampicin/multidrug‐resistant tuberculosis patients. Patient Relat Outcome Meas. 2021;12:205–212. https://doi.org/10.2147/PROM.S316337
Jaber AAS, Ibrahim B. Health‐related quality of life of patients with multidrug‐resistant tuberculosis in Yemen: prospective study. Health Qual Life Outcomes. 2019;17(1):142. https://doi.org/10.1186/s12955-019-1211-0
European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2021 –2019 data. 2021 [cited 2022 Feb 16]. Available from: https://www.ecdc.europa.eu/en/publications-data/tuberculosis-surveillance-and-monitoring-europe-2021-2019-data
corporate‐body.COM:European Commission, corporate‐body. SG:Secretariat‐General. SWD/2020/522 final. COMMISSION STAFF WORKING DOCUMENT Country Report Romania 2020 Accompanying the document COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE EUROPEAN COUNCIL, THE COUNCIL, THE EUROPEAN CENTRAL BANK AND THE EUROGROUP 2020 European Semester: Assessment of progress on structural reforms, prevention and correction of macroeconomic imbalances, and results of in‐depth reviews under Regulation (EU) No 1176/2011. 2020 [cited 2022 Feb 16]. Available from: https://op.europa.eu/en/publication-detail/-/publication/8b39ae9a-5945-11ea-8b81-01aa75ed71a1/language-en/format-PDF
Chushkin M, Maliev B, Belevskiy A, Meshcheryakova N, Bukhareva S, Smerdin S. Using SF‐36 in assessment of quality of life in patients cured of pulmonary tuberculosis. Eur Respir J. 2011;38(Suppl 55):2591. https://erj.ersjournals.com/content/38/Suppl_55/p2591
Chamla D. The assessment of patients' health‐related quality of life during tuberculosis treatment in Wuhan, China. Int J Tuberc Lung Dis. 2004 Sep;8(9):1100–1106. https://www.ncbi.nlm.nih.gov/pubmed/15455595
Mardare I, Furtunescu FL, Bratu EC, Anastasievici L. Measuring health related quality of life – methods and tools. [cited 2023 Jun 2]. Available from: http://www.amtsibiu.ro/Arhiva/2019/Nr2-en/Mardare.pdf
Park HY, Cheon HB, Choi SH, Kwon JW. Health‐related quality of life based on EQ‐5D utility score in patients with tuberculosis: a systematic review. Front Pharmacol. 2021;12:659675. https://doi.org/10.3389/fphar.2021.659675
Olariu E, Mohammed W, Oluboyede Y, Caplescu R, Niculescu‐Aron IG, Paveliu MS, et al. EQ‐5D‐5L: a value set for Romania. Eur J Health Econ. 2022;24:399–412. https://doi.org/10.1007/s10198-022-01481-7
Paveliu MS, Olariu E, Caplescu R, Oluboyede Y, Niculescu‐Aron IG, Ernu S, et al. Estimating an EQ‐5D‐3L value set for Romania using time trade‐off. Int J Environ Res Public Health. 2021;18(14):7415. https://doi.org/10.3390/ijerph18147415
Hubens K, Krol M, Coast J, Drummond MF, Brouwer WBF, Uyl‐de Groot CA, et al. Measurement instruments of productivity loss of paid and unpaid work: a systematic review and assessment of suitability for health economic evaluations from a societal perspective. Value Health. 2021;24:1686–1699. https://doi.org/10.1016/j.jval.2021.05.002
Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH, et al. Assessing productivity loss and activity impairment in severe or difficult‐to‐treat asthma. Value Health. 2008;11(2):231–239. https://doi.org/10.1111/j.1524-4733.2007.00229.x
Ong Z‐T, Lam B, Ooi K, Watcharasupat KN, Wong T, Gan W‐S. Do uHear? Validation of uHear app for preliminary screening of hearing ability in soundscape studies. arXiv preprint arXiv. Available from: https://www.researchgate.net/profile/Bhan‐Lam/publication/362121556_Do_uHear_Validation_of_uHear_App_for_Preliminary_Screening_of_Hearing_Ability_in_Soundscape_Studies/links/62d760f6593dae2f6a2a48c1/Do‐uHear‐Validation‐of‐uHear‐App‐for‐Preliminary‐Screening‐of‐Hearing‐Ability‐in‐Soundscape‐Studies.pdf
Szudek J, Ostevik A, Dziegielewski P, Robinson‐Anagor J, Gomaa N, Hodgetts B, et al. Can Uhear me now? Validation of an iPod‐based hearing loss screening test. J Otolaryngol Head Neck Surg. 2012;41(Suppl 1):S78–S84. https://www.ncbi.nlm.nih.gov/pubmed/22569055
Al‐Abri R, Al‐Balushi M, Kolethekkat A, Bhargava D, Al‐Alwi A, Al‐Bahlani H, et al. The accuracy of IOS device‐based uHear as a screening tool for hearing loss: a preliminary study from the Middle East. Oman Med J. 2016;31(2):142–145. https://doi.org/10.5001/omj.2016.27
Housing in Europe. Housing in Europe – size of housing. [cited 2023 Feb 14]. Available from: https://ec.europa.eu/eurostat/cache/digpub/housing/bloc-1b.html?lang=en
Migliori GB, Garcia‐Basteiro AL. Predicting the effect of improved socioeconomic health determinants on the tuberculosis epidemic. Lancet Glob Health. 2018;6(5):e475–e476. https://doi.org/10.1016/S2214-109X(18)30189-X
Amere GA, Nayak P, Salindri AD, Narayan KMV, Magee MJ. Contribution of smoking to tuberculosis incidence and mortality in high‐tuberculosis‐burden countries. Am J Epidemiol. 2018;187(9):1846–1855. https://doi.org/10.1093/aje/kwy081
Rural population (% of total population) – Romania [cited 2023 Feb 16]. Available from: https://data.worldbank.org/indicator/SP.RUR.TOTL.ZS?locations=RO
Atif M, Ahmed W, Nouman Iqbal M, Ahmad N, Ahmad W, Malik I, et al. Frequency and factors associated with adverse events among multi‐drug resistant tuberculosis patients in Pakistan: a retrospective study. Front Med. 2021;8:790718. https://doi.org/10.3389/fmed.2021.790718
Roba AA, Dasa TT, Weldegebreal F, Asfaw A, Mitiku H, Teklemariam Z, et al. Tuberculosis patients are physically challenged and socially isolated: a mixed methods case‐control study of health related quality of life in eastern Ethiopia. PLoS One. 2018;13(10):e0204697. https://doi.org/10.1371/journal.pone.0204697
Ahmad N, Javaid A, Syed Sulaiman SA, Basit A, Afridi AK, Jaber AAS, et al. Effects of multidrug resistant tuberculosis treatment on Patients' health related quality of life: results from a follow up study. PLoS One. 2016;11(7):e0159560. https://doi.org/10.1371/journal.pone.0159560
Dody Izhar M, Butar MB, Hidayati F, Ruwayda R. Predictors and health‐related quality of life with short form‐36 for multidrug‐resistant tuberculosis patients in Jambi, Indonesia: a case‐control study. Clinic Epidemiol Global Health. 2021;12:100872. https://doi.org/10.1016/j.cegh.2021.100872
Ramkumar S, Vijayalakshmi S, Seetharaman N, Pajanivel R, Lokeshmaran A. Health‐related quality of life among tuberculosis patients under Revised National Tuberculosis Control Programme in rural and urban Puducherry. Indian J Tuberc. 2017;64(1):14–19. https://doi.org/10.1016/j.ijtb.2016.11.004
BMJ. Tuberculosis patients need better mental health support, especially in the time of COVID‐19. The BMJ. 2020 [cited 2023 Feb 16]. Available from: https://blogs.bmj.com/bmj/2020/10/09/tuberculosis-patients-need-better-mental-health-support-especially-in-the-time-of-covid-19/
Guo N, Marra F, Marra CA. Measuring health‐related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes. 2009;7:14. https://doi.org/10.1186/1477-7525-7-14
metodologic de implementare a Programului G. naţional de prevenire, supraveghere şi control al tuberculozei. București, 2015. ISBN 978‐973‐139‐325‐4. Ordinul Ministerului Sănătăţii; 2015.
Migliori GB, Visca D, van den Boom M, Tiberi S, Silva DR, Centis R, et al. Tuberculosis, COVID‐19 and hospital admission: consensus on pros and cons based on a review of the evidence. Pulmonology. 2021;27(3):248–256. https://doi.org/10.1016/j.pulmoe.2020.12.016
Verma J, Syed MT. Evaluating hearing loss in patients undergoing second line anti tubercular treatment. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 2):1202–1206. https://doi.org/10.1007/s12070-018-1266-y
Varaine F, Rich ML, Grouzard V. Tuberculosis: practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries. Med Sans Front Partners Health.
Médecins Sans Frontières (MSF) International [Internet]. Step up for TB report 2020 [cited 2023 Mar 9]. Available from: https://www.msf.org/step-tb-report-2020
Ariadna Petronela F, Daniela H, Beatrice M, Ramona Elena N, Cristian George P, Gilda Georgeta P. TUBERCULOZA MANUAL PENTRU PROFESIONIȘTII DIN SĂNĂTATE [Internet]. 2022 Available from: https://marius‐nasta.ro/wp‐content/uploads/2022/07/Manual‐TB‐FINAL_A‐1.pdf
Popovici O, Șerban R, Janță D, Moisoiu A, Arbore AS, Dragoș M, et al. Strategia Națională pentru Controlul Tuberculozei în România – 2022‐2030. Governmental General Secretariat.
Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. BMJ. 2015;350:g7818. https://doi.org/10.1136/bmj.g7818
Margineanu I, Louka C, Vincenti‐Gonzalez M, Saktiawati AMI, Schierle J, Abass KM, et al. Patients and medical staff attitudes toward the future inclusion of ehealth in tuberculosis management: perspectives from six countries evaluated using a qualitative framework. JMIR MHealth UHealth. 2020;8(11):e18156. https://doi.org/10.2196/18156
Margineanu I, Louka C, Akkerman O, Stienstra Y, Alffenaar JW. eHealth in TB clinical management. Int J Tuberc Lung Dis. 2022;26(12):1151–1161. https://doi.org/10.5588/ijtld.21.0602